PTGX
Price:
$40.6
Market Cap:
$2.42B
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 integrin- specific antagonist peptide that is in Phase II clinical trials for treating inflammatory bowel disease (IBD); and PN-235, an orally delivered interleukin-23 receptor specific antagonist for the treatment ...[Read more]
Industry
Biotechnology
IPO Date
2016-08-11
Stock Exchange
NASDAQ
Ticker
PTGX
According to Protagonist Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Protagonist Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), PTGX's Dividend Yield was at its highest in in the March 2015 quarter at 0%. The Dividend Yield was at its lowest in in the March 2015 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Protagonist Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
2018 | 0% | 0% |
2017 | 0% | 0% |
2016 | 0% | 0% |
2015 | 0% | 0% |
The current Dividend Yield of Protagonist Therapeutics, Inc. (PTGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Protagonist Therapeutics, Inc.’s Dividend Yield is less than Revolution Medicines, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Kura Oncology, Inc. (0%), less than Merus N.V. (0%), less than Replimune Group, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Pliant Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than IDEAYA Biosciences, Inc. (0%), less than Verona Pharma plc (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Terns Pharmaceuticals, Inc. (0%), less than X4 Pharmaceuticals, Inc. (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than HOOKIPA Pharma Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $8.01B | |
0% | $1.98B | |
0% | $3.77B | |
0% | $614.95M | |
0% | $695.21M | |
0% | $2.91B | |
0% | $929.70M | |
0% | $8.19B | |
0% | $726.44M | |
0% | $811.79M | |
0% | $123.92M | |
0% | $1.24B | |
0% | $166.17M | |
0% | $2.19B | |
0% | $3.71B | |
0% | $1.14B | |
0% | $503.69M | |
0% | $98.42M | |
0% | $106.34M | |
0% | $1.28B | |
0% | $19.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protagonist Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Protagonist Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Protagonist Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Protagonist Therapeutics, Inc. (PTGX)?
What is the highest Dividend Yield for Protagonist Therapeutics, Inc. (PTGX)?
What is the 3-year average Dividend Yield for Protagonist Therapeutics, Inc. (PTGX)?
What is the 5-year average Dividend Yield for Protagonist Therapeutics, Inc. (PTGX)?
How does the current Dividend Yield for Protagonist Therapeutics, Inc. (PTGX) compare to its historical average?